Sparano, J.A., et al. (June 3, 2018) Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. New England Journal of Medicine. Available online at http://dx.doi.org/ 10.1056/NEJMoa1804710. Accessed on June 26, 2018.
Fisher, A. (June 3, 2018) American Society of Clinical Oncology, Press Release. Most women with early stage breast cancer can forgo chemotherapy when guided by a diagnostic test. Available online at www.asco.org/about-asco/press-center/news-releases/most-women-early-stage-breast-cancer-can-forgo-chemotherapy. Accessed on June 26, 2018.
Ritter, J. (June 3, 2018) EurekAlert!, Press Release. Landmark study finds more breast cancer patients can safely forgo chemotherapy. Available online at www.eurekalert.org/pub_releases/2018-06/luhs-lsf053118.php. Accessed on June 26, 2018.
Watson, S.K. (June 3, 2018) NPR, Health Shots. For some breast cancer patients, the chemo decision just got easier. Available online at www.npr.org/sections/health-shots/2018/06/03/616298863/for-some-breast-cancer-patients-the-chemo-decision-just-got-easier. Accessed on June 26, 2018.
Ashford, M. (June 3, 2018) GenomeWeb. Fewer breast cancer patients benefit from chemo, TAILORx study with Oncotype DX finds. Available online at www.genomeweb.com/molecular-diagnostics/fewer-breast-cancer-patients-benefit-chemo-tailorx-study-oncotype-dx-finds#.WzItOy2B3BJ. Accessed on June 26, 2018.
(February 14, 2017) Breastcancer.org. Managing chemotherapy side effects. Available online at www.breastcancer.org/treatment/chemotherapy/side_effects. Accessed on June 26, 2018.
(June 3, 2018) OncotypeIQ, Announcement. Celebrating TAILORx and all who made it possible. Available online at www.oncotypeiq.com/en-US/announcements/TAILORx. Accessed on June 26, 2018.